Overexpression of thioredoxins 1 and 2 increases retinal ganglion cell survival after pharmacologically induced oxidative stress, optic nerve transection, and in experimental glaucoma

Transactions of the American Ophthalmological Society

Volumn 107, Issue , 2009, Pages 161-165

  Caprioli, Joseph ^a   Munemasa, Yasunari ^a   Kwong, Jacky M K ^a   Piri, Natik ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; DEXTRAN TETRAMETHYLRHODAMINE; GLUTAMIC ACID; INDIAN INK; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY THY 1; TETRAMETHYLRHODAMINE; THIOREDOXIN 1; THIOREDOXIN 2; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL LABELING; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DIODE LASER; ELECTROPORATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; GLAUCOMA; IMMUNOBLOTTING; IN VIVO STUDY; INTRAOCULAR HYPERTENSION; MAGNETISM; MALE; NERVE CELL CULTURE; NERVE FIBER TRANSECTION; NONHUMAN; OPTIC NERVE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RETINA; RETINA BIPOLAR GANGLION CELL; RETINA GANGLION CELL; UPREGULATION;

ANIMALS; CARBON; CELL LINE; CELL SURVIVAL; GLAUCOMA; INJECTIONS; MALE; NEUROPROTECTIVE AGENTS; OPTIC NERVE INJURIES; OXIDATIVE STRESS; RATS; RATS, WISTAR; RETINAL GANGLION CELLS; THIOREDOXINS; UP-REGULATION;

EID: 77949403644     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 2006;25:490-513.
2. Kumar DM, Agarwal N. Oxidative stress in glaucoma: a burden of evidence. J Glaucoma 2007;16:334-343.
3. Masutani H, Ueda S, Yodoi J. The thioredoxin system in retroviral infection and apoptosis. Cell Death Differ 2005;12:991-998.
4. Saitoh M, Nishitoh H, Fujii M, et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998;17:2596-2606.
5. Wang D, Masutani H, Oka S, et al. Control of mitochondrial outer membrane permeabilization and Bcl-xL levels by thioredoxin 2 in DT40 cells. J Biol Chem 2006;281:7384-7391.
6. Nonn L, Williams RR, Erickson RP, Powis G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 2003;23:916-922.
7. Nishiyama A, Matsui M, Iwata S, et al. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 1999;274:21645-21650.
8. Munemasa Y, Kim SH, Ahn JH, et al. Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress. Invest Ophthalmol Vis Sci 2008;49:3535-3543.
9. Munemasa Y, Ahn JH, Kwong JM, et al. Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma. Gene Ther 2009;16:17-25.
10. Ishii Y, Kwong JM, Caprioli J. Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model. Invest Ophthalmol Vis Sci 2003;44:1982-1992.
11. Kwong JM, Lalezary M, Nguyen JK, et al. Co-expression of heat shock transcription factors 1 and 2 in rat retinal ganglion cells. Neurosci Lett 2006;405:191-195.
12. Piri N, Song M, Kwong JM, Caprioli J. Modulation of alpha and beta crystallin expression in rat retinas with ocular hypertension-induced ganglion cell degeneration. Brain Res 2007;1141:1-9.
13. Dezawa M, Takano M, Negishi H, et al. Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach. Micron 2002;33:1-6.
14. Ishikawa H, Takano M, Matsumoto N, et al. Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode. Gene Ther 2005;12:289-298.
15. Tanito M, Kwon YW, Kondo N. Cytoprotective effects of geranylgeranylacetone against retinal photooxidative damage. J Neurosci 2005;25:2396-2404.
16. Thanos S, Mey J, Wild M. Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci 1993;13:455-466.
17. Nguyen SM, Alexejun CN, Levin LA. Amplification of a reactive oxygen species signal in axotomized retinal ganglion cells. Antioxid Redox Signal 2003;5:629-634.
18. Geiger LK, Kortuem KR, Alexejun C, Levin LA. Reduced redox state allows prolonged survival of axotomized neonatal retinal ganglion cells. Neuroscience 2002;109:635-642.
19. Koeberle PD, Ball AK. Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells. Exp Neurol 1999;158:366-381.
20. Tezel G, Wax MB. Glial modulation of retinal ganglion cell death in glaucoma. J Glaucoma 2003;12:63-68.